Ofatumumab demonstrates activity against rituximab-sensitive and -resistant cell lines, lymphoma xenografts and primary tumour cells from patients with B-cell lymphoma

✍ Scribed by Matthew J. Barth; Francisco J. Hernandez-Ilizaliturri; Cory Mavis; Ping-Chiao Tsai; John F. Gibbs; George Deeb; Myron S. Czuczman

• Book ID: 108677518
• Publisher: John Wiley and Sons
• Year: 2011
• Tongue: English
• Weight: 338 KB
• Volume: 156
• Category: Article
• ISSN: 0007-1048
• DOI: 10.1111/j.1365-2141.2011.08966.x